Profile data is unavailable for this security.
About the company
Japan Tissue Engineering Co Ltd is a Japan-based company mainly engaged in regenerative medicine product business, regenerative medicine outsourcing business, and research and development support business. The Company operates through three segments. The Regenerative Medicine Product segment develops regenerative medicine products using tissue engineering, and manufactures and sells the products for medical institutions. The regenerative medicine products include autologous cultured epidermis JACE, and autologous cultured cartilage JACK. The Regenerative Medicine Outsourcing segment provides contract development and manufacturing organization (CDMO) services, contract research organization (CRO) services, consulting services, and contract manufacturing services for specific cell processed products. The Research and Development Support segment manufactures and sells human cultured tissues that apply advanced culture technology accumulated through the development of in-house products.
- Revenue in JPY (TTM)2.43bn
- Net income in JPY-70.51m
- Incorporated1999
- Employees211.00
- LocationJapan Tissue Engineering Co Ltd6-209-1, Miyakita-doriGAMAGORI-SHI 443-0022JapanJPN
- Phone+81 533662020
- Fax+81 533662019
- Websitehttps://www.jpte.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EcoNaviSta Inc | 1.20bn | 281.96m | 10.53bn | 35.00 | 41.38 | 3.26 | 34.85 | 8.78 | 38.65 | 38.65 | 170.53 | 490.67 | 0.3896 | 1.52 | 18.36 | 34,260,280.00 | 9.16 | -- | 9.85 | -- | 66.17 | -- | 23.51 | -- | 15.45 | -- | 0.00 | -- | 21.55 | -- | 38.02 | -- | -- | -- |
| JMS Co Ltd | 67.87bn | -36.00m | 10.96bn | 5.28k | -- | 0.2684 | 2.88 | 0.1614 | -1.47 | -1.47 | 2,772.01 | 1,650.80 | 0.8213 | 2.64 | 3.80 | 12,847,620.00 | -0.0508 | 1.33 | -0.0738 | 1.97 | 21.95 | 24.29 | -0.0619 | 1.57 | 1.07 | 0.5419 | 0.3832 | 43.31 | 2.43 | 2.38 | -112.81 | -- | -2.42 | 1.22 |
| OLBA Healthcare Holdings Inc | 120.11bn | 1.50bn | 12.63bn | 1.35k | 7.99 | 1.08 | 6.07 | 0.1052 | 252.91 | 252.91 | 20,250.40 | 1,863.86 | 2.83 | 16.30 | 4.80 | 88,710,020.00 | 3.53 | 3.00 | 11.89 | 10.37 | 11.50 | 11.29 | 1.25 | 1.04 | 0.9459 | 742.06 | 0.214 | 32.62 | 7.33 | 1.99 | 6.09 | 14.11 | -2.58 | 14.87 |
| Seed Co Ltd | 33.28bn | 1.69bn | 14.10bn | 962.00 | 7.51 | 0.8033 | 2.88 | 0.4238 | 62.04 | 62.04 | 1,188.74 | 580.10 | 0.7045 | 2.80 | 7.78 | 34,592,670.00 | 3.65 | 1.99 | 6.06 | 3.51 | 43.13 | 42.31 | 5.18 | 2.74 | 0.7949 | 11.28 | 0.5962 | 39.56 | 5.89 | 1.90 | 721.44 | 15.30 | 20.42 | 4.56 |
| HOSHI IRYO-SANKI CO., LTD | 15.10bn | 1.41bn | 14.43bn | 486.00 | 9.35 | 0.7406 | 11.69 | 0.9558 | 451.24 | 451.24 | 4,843.61 | 5,697.90 | 0.6667 | 27.37 | 5.97 | 31,069,800.00 | 6.28 | 5.66 | 7.79 | 7.19 | 48.80 | 49.04 | 9.42 | 8.65 | 3.08 | -- | 0.00 | 16.34 | 7.25 | 6.42 | 12.01 | 10.04 | -13.23 | 8.45 |
| Kusurinomadoguchi Inc | 9.91bn | 897.35m | 15.11bn | 505.00 | 16.30 | 2.18 | 7.28 | 1.52 | 84.43 | 84.43 | 943.55 | 630.97 | 0.5277 | -- | 3.03 | 19,623,970.00 | 4.71 | -- | 15.84 | -- | 57.76 | -- | 8.92 | -- | -- | 31.52 | 0.034 | -- | 17.53 | -- | 122.49 | -- | -- | -- |
| Techno Medica Co Ltd | 10.34bn | 1.19bn | 15.91bn | 237.00 | 10.86 | 0.9252 | 12.22 | 1.54 | 167.16 | 167.16 | 1,442.43 | 1,962.83 | 0.6031 | 2.25 | 4.45 | 43,647,340.00 | 6.96 | 6.68 | 8.04 | 7.80 | 49.98 | 48.86 | 11.53 | 12.31 | 4.51 | 138.02 | 0.00 | 39.33 | 9.78 | 1.96 | 17.15 | 4.19 | 0.7168 | 7.67 |
| Daiken Medical Co Ltd | 9.84bn | 1.06bn | 16.05bn | 175.00 | 13.66 | 1.99 | 12.50 | 1.63 | 36.89 | 36.89 | 342.51 | 253.63 | 0.8693 | 3.90 | 3.87 | 56,226,790.00 | 9.36 | 7.44 | 13.25 | 10.84 | 41.33 | 41.74 | 10.77 | 9.28 | 1.90 | 301.85 | 0.2527 | 71.35 | 6.71 | 3.01 | 38.84 | 3.03 | -4.01 | 0.9806 |
| Japan Medical Dynamic Marketing, INC. | 24.04bn | 1.41bn | 16.42bn | 511.00 | 11.59 | 0.6578 | 5.30 | 0.6827 | 53.49 | 53.49 | 913.02 | 942.48 | 0.7806 | 0.6718 | 4.53 | 47,051,430.00 | 4.71 | 6.51 | 5.44 | 7.53 | 63.41 | 66.97 | 6.04 | 8.88 | 1.82 | -- | 0.0895 | 18.33 | 8.78 | 6.74 | -10.68 | -8.52 | -2.95 | 9.24 |
| Medical Data Vision Co Ltd | 6.06bn | 4.79m | 17.33bn | 262.00 | 3,452.40 | 4.44 | 242.45 | 2.86 | 0.1254 | 0.1254 | 158.59 | 97.57 | 1.12 | 252.23 | 8.53 | 23,120,150.00 | -0.4652 | 16.16 | -0.6367 | 20.88 | 75.68 | 81.90 | -0.4147 | 15.52 | 2.59 | 4.57 | 0.00 | 19.98 | 5.15 | 12.40 | 12.48 | 69.75 | -23.95 | -- |
| Medius Holdings Co Ltd | 268.79bn | 1.11bn | 17.43bn | 2.52k | 15.61 | 0.8971 | 5.83 | 0.0649 | 50.24 | 50.24 | 12,186.68 | 873.94 | 2.49 | 18.80 | 4.97 | 106,790,700.00 | 1.03 | 1.73 | 3.98 | 6.34 | 11.91 | 11.83 | 0.4112 | 0.6565 | 0.9191 | -- | 0.5637 | 28.32 | 8.67 | 5.62 | -24.92 | -- | 16.48 | 8.45 |
| Japan Tissue Engineering Co., Ltd. | 2.43bn | -70.51m | 20.06bn | 211.00 | -- | 3.43 | 266.84 | 8.26 | -1.74 | -1.74 | 59.82 | 144.18 | 0.3663 | 4.63 | 5.38 | 11,513,990.00 | -1.06 | -4.72 | -1.19 | -5.31 | 63.29 | 57.30 | -2.90 | -16.38 | 7.97 | -295.27 | 0.00 | -- | 23.70 | 1.29 | 119.63 | -- | 30.22 | -- |
| Findex Inc | 6.03bn | 1.32bn | 21.61bn | 290.00 | 15.74 | 3.95 | 15.40 | 3.58 | 51.60 | 51.60 | 234.94 | 205.65 | 1.07 | 6.88 | 5.67 | 20,784,770.00 | 23.57 | 15.72 | 25.98 | 18.41 | 63.02 | 56.81 | 21.93 | 14.58 | 8.30 | -- | -- | 36.20 | 14.32 | 7.58 | 46.54 | 21.62 | -3.34 | 11.63 |
| Rion Co Ltd | 26.67bn | 2.59bn | 29.68bn | 1.03k | 11.43 | 0.9848 | 8.09 | 1.11 | 210.52 | 210.52 | 2,165.88 | 2,443.26 | 0.7227 | 1.73 | 4.12 | 25,990,020.00 | 7.03 | 6.27 | 8.17 | 7.25 | 50.40 | 50.29 | 9.72 | 8.85 | 2.41 | -- | 0.00 | 28.11 | 7.79 | 3.86 | 47.39 | 5.78 | 25.24 | 4.56 |
Data as of Nov 22 2024. Currency figures normalised to Japan Tissue Engineering Co Ltd's reporting currency: Japanese Yen JPY
0.19%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Simplex Asset Management Co., Ltd.as of 07 Nov 2024 | 72.80k | 0.18% |
| Sawakami Asset Management, Inc.as of 30 Aug 2024 | 6.20k | 0.02% |
Data from 30 Aug 2024 - 14 Nov 2024Source: FactSet Research Systems Inc.
